Mark For: EGRIFTA SV® trademark registration is intended to cover the categories of
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 88200431 |
Registration Number | 6077575 |
Mark Literal Elements | EGRIFTA SV |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK |
Register | PRINCIPAL |
Current Location | PUBLICATION AND ISSUE SECTION 2020-06-16 |
Basis | 1(a) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | Yes |
Intent To Use | No |
Filed ITU | Yes |
44D Filed | Yes |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Jay A. Bondell, Esq. |
Attorney Docket Number | 0236-001/JAB |
Law Office Assigned | O10 |
Employee Name | HOFFMAN, CHRISTOPHER J |
2018-11-20 | Application Filed |
2019-10-22 | Location: TMO LAW OFFICE 128 - EXAMINING ATTORNEY ASSIGNED |
2019-10-22 | Status: Live/Pending |
2019-10-22 | Transaction Date |
2019-12-03 | Date of First Use |
2019-12-03 | Date of Use In Commerce |
2020-03-31 | Published |
2020-06-16 | Location: PUBLICATION AND ISSUE SECTION |
2020-06-16 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
2020-06-16 | Trademark Registered |
Party: | ![]() |
Address | Suite 500 2015 Peel Street Montreal. Quebeck CANADA H3A1T8 |
Legal Entity Type | Corporation |
Legal Entity State | CANADA |
![]() | JPEG | 2018-11-20 |
![]() | MULTI | 2018-11-20 |
![]() | XML | 2019-03-03 |
![]() | XML | 2019-03-03 |
![]() | XML | 2019-10-22 |
![]() | MULTI | 2020-02-12 |
![]() | IMAGE/JPEG | 2020-02-12 |
![]() | MULTI | 2020-02-25 |
![]() | XML | 2020-02-26 |
![]() | MULTI | 2020-02-26 |
![]() | XML | 2020-03-11 |
![]() | XML | 2020-03-11 |
![]() | APPLICATION/XML | 2020-03-31 |
![]() | 2020-06-16 |
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for the treatment of lipodystrophy, obesity, wasting, growth hormone deficiency, cognitive impairment and traumatic brain injury. FIRST USE: 20191203. FIRST USE IN COMMERCE: 20191203
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical preparations for the treatment of lipodystrophy, obesity, wasting, growth hormone deficiency, cognitive impairment and traumatic brain injury |
GS0051 | Pharmaceutical preparations for the treatment of lipodystrophy, obesity, wasting, growth hormone deficiency, cognitive impairment and traumatic brain injury |
Description | Date | Proceeding Number |
---|---|---|
REGISTERED-PRINCIPAL REGISTER | 2020-06-16 | |
PUBLISHED FOR OPPOSITION | 2020-03-31 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-03-31 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-03-11 | |
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | 2020-02-26 | |
USE AMENDMENT ACCEPTED | 2020-02-25 | 94479 |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-02-25 | |
USE AMENDMENT FILED | 2020-02-24 | 68552 |
AMENDMENT TO USE PROCESSING COMPLETE | 2020-02-24 | 68552 |
TEAS AMENDMENT OF USE RECEIVED | 2020-02-12 | |
SUSPENSION INQUIRY WRITTEN | 2019-10-22 | 94479 |
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | 2019-10-22 | |
INQUIRY TO SUSPENSION E-MAILED | 2019-10-22 | |
ASSIGNED TO EXAMINER | 2019-10-22 | 94479 |
LIE CHECKED SUSP - TO ATTY FOR ACTION | 2019-09-30 | 68552 |
ASSIGNED TO LIE | 2019-09-25 | 68552 |
SUSPENSION LETTER WRITTEN | 2019-03-03 | 81857 |
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2019-03-03 | 6332 |
LETTER OF SUSPENSION E-MAILED | 2019-03-03 | 6332 |
ASSIGNED TO EXAMINER | 2019-02-24 | 81857 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-12-08 | |
NEW APPLICATION ENTERED IN TRAM | 2018-11-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.